z-logo
open-access-imgOpen Access
Respiratory infections regulated blood cells IFN‐β‐PD‐L1 pathway in pediatric asthma
Author(s) -
Kölle Julia,
Haag Patricia,
Vuorinen Tytti,
Alexander Kiefer,
Rauh Manfred,
Zimmermann Theodor,
Papadopoulos Nikolaos G.,
Finotto Susetta
Publication year - 2020
Publication title -
immunity, inflammation and disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 18
ISSN - 2050-4527
DOI - 10.1002/iid3.307
Subject(s) - asthma , respiratory system , immunology , medicine
Background Respiratory infections, in general, and rhinovirus infection specifically are the main reason for asthma exacerbation in children and programmed cell death protein 1 ligand (PD‐L1) expression inhibits T cell responses. Objective Could the interferon (IFN) type I expression in peripheral blood mononuclear cells (PBMCs) improve disease exacerbation in pediatric asthma? Results Here we found increased level of PD‐L1 messenger RNA (mRNA) in total blood cells isolated from preschool children with virus‐induced asthma, with lower percentage of forced expiratory volume in 1 second and with high serum levels of the C‐reactive‐protein. Conclusions and Clinical Relevance These data indicate that, in the presence of infection in the airways of preschool children, worse asthma is associated with induced PD‐L1 mRNA expression in blood cells. Further, type I IFN, IFN‐β, a cytokine that is involved in the clearance of infections, was found to be associated with a better lung function in asthmatic children. These data suggest that improving peripheral blood IFN type I expression in PBMCs in pediatric asthma could improve disease exacerbation due to suppressing PD‐L1 expression in blood cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here